Viewing Study NCT00525668


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-20 @ 6:33 PM
Study NCT ID: NCT00525668
Status: COMPLETED
Last Update Posted: 2021-07-29
First Post: 2007-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)
Sponsor: Charite University, Berlin, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing-remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple sclerosis View
None inflammation View
None neurodegeneration View
None neuroprotection View